Home › Knowledge › Medicare Part D
Vedanth Bhartee
Writer · Reviewed by Richard ChanUpdated Jun 12, 2026
2 min read
Rybelsus, a prescription medication used to treat type 2 diabetes, is typically covered under Medicare Part D prescription drug plans.
Medicare coverage for Rybelsus is strictly for the FDA-approved indication of managing type 2 diabetes and is not covered when prescribed solely for weight loss.
Beneficiary out-of-pocket costs for Rybelsus will depend on the specific Part D plan's formulary tiers, deductibles, and whether the beneficiary has entered the coverage gap.
Rybelsus is an essential medication for managing type 2 diabetes, providing patients with a convenient once-daily pill regimen approved by the FDA. This groundbreaking treatment aims to lower blood sugar levels and mitigate the risk of cardiovascular events. Unlike other GLP-1 medications, which are injections, Rybelsus is an oral tablet, making it a more accessible option for many.
In this article, we delve into the active ingredients of Rybelsus, the companies selling it, and crucially, the Medicare coverage options available for this vital medication.
The active ingredient in Rybelsus is semaglutide, a potent glucagon-like peptide-1 (GLP-1) agonist that plays a pivotal role in regulating blood sugar levels and promoting weight loss. It mimics the action of GLP-1 hormone, which helps stimulate insulin production and decreases glucose production by the liver. This leads to improved glycemic control in patients with type 2 diabetes.
Novo Nordisk, the manufacturer of Rybelsus, lists the price for a 30-tablet supply of Rybelsus as $935.77. This price is applicable to tablets of all strengths, including 3 mg, 7 mg, and 14 mg.
Novo Nordisk is a leading Danish pharmaceutical company specializing in diabetes care and treatment. As a trusted provider of diabetes therapies, Novo Nordisk ensures the quality, safety, and efficacy of Rybelsus.
Choosing the right Medicare plan is crucial for Rybelsus coverage, as there can be significant cost disparities. Understanding the subtleties of coverage under Medicare Part D is vital to maximize benefits. Nearly 90% of Medicare prescription drug plans cover Rybelsus, but costs can vary depending on the plan. Rybelsus copay ranges can start as low as $10 per prescription under standard coverage. However, once you meet the deductible, the specific plan’s coverage and copayments will influence Rybelsus costs.
This proactive approach to cost-saving ensures that you can maximize your savings and minimize out-of-pocket expenses for essential medications.
Patient assistance programs (PAPs) can provide financial assistance or free medication to individuals with low income, limited health insurance, or coverage gaps.
Understanding the eligibility criteria and application process for PAPs specific to Rybelsus can help you access affordable treatment options and alleviate financial burdens associated with managing type 2 diabetes.
While Medicare Part D generally offers coverage for prescription medications like Rybelsus, it’s essential to confirm whether the specific Medicare plan’s formulary covers Rybelsus.
Understanding the coverage limitations, copayments, and restrictions associated with Rybelsus under Medicare Part D can help you make informed decisions regarding your healthcare coverage and medication management strategies.